Indeed, MEG3 can sequester: • hsa-miR-650 to release the expression of SLC34A2, in NSCLC cell line (H1299) [159] • hsa-miR-7-5p to release the expression of BRCA1, in NSCLC tumor tissues and BEAS-2B, A549, and HCC823 cell lines [156] • hsa-miR-21-5p to release the expression of SOX7, in DDP-resistant NSCLC tumor tissues and A549 and H1299 cell lines [117] • hsa-miR-3163 to release the expression of SKP2 that will, in turn, promotes the ubiquitination-associated degradation of p27 (CDKN1B), in NSCLC tumor tissues and A549 cell lines [153] • hsa-miR-205-5p to release the expression of LRP1. The gene discussed is SLC34A2; the disease is non-small cell lung carcinoma.